Literature DB >> 10921376

Natural history of hepatitis B virus infection in children.

M H Chang1.   

Abstract

Hepatitis B virus (HBV) infection during childhood can cause acute, fulminant or chronic hepatitis, liver cirrhosis, and liver cancer. Approximately 90% of the infants of hepatitis B e antigen (HBeAg) seropositive mothers become hepatitis B surface antigen (HBsAg) carriers. Children chronically infected are mostly asymptomatic. Although liver damage is usually mild during childhood, severe liver disease, including cirrhosis and hepatocellular carcinoma, may develop insidiously for 2-7 years. Spontaneous HBeAg seroconversion occurs gradually as the age of the child increases. Viral replication is reduced during this process, which is usually preceded by an elevation of aminotransferases. In a long-term follow-up study, the annual HBeAg seroconversion rate was 4-5% in children older than 3 years of age and less than 2% in children under 3 years. The annual seroconversion rate of HBsAg was very low (0.56%). Age at infection, maternal HBsAg and HBeAg status, host immune status, and possibly the HBV strain are the main factors determining the course of HBV infection in children.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10921376     DOI: 10.1046/j.1440-1746.2000.02096.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  17 in total

1.  Decline in immature transitional B cells after hepatitis B vaccination in hepatitis B positive newborns.

Authors:  Shikha Shrivastava; Nirupama TrehanPati; Shyam Kottilil; Shiv Kumar Sarin
Journal:  Pediatr Infect Dis J       Date:  2013-07       Impact factor: 2.129

2.  Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series.

Authors:  Calvin Q Pan; Li-Jun Mi; Chalermrat Bunchorntavakul; Jeffrey Karsdon; William M Huang; Gaurav Singhvi; Marc G Ghany; K Rajender Reddy
Journal:  Dig Dis Sci       Date:  2012-04-29       Impact factor: 3.199

Review 3.  Hepatitis B During Pregnancy in Endemic Areas: Screening, Treatment, and Prevention of Mother-to-Child Transmission.

Authors:  Naichaya Chamroonkul; Teerha Piratvisuth
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

4.  Seroprevalence of Hepatitis B Infection in Nigeria: A National Survey.

Authors:  Adebola T Olayinka; Akin Oyemakinde; Muhammad S Balogun; Anthonia Ajudua; Patrick Nguku; Moses Aderinola; Abiodun Egwuenu-Oladejo; Simeon W Ajisegiri; Samuel Sha'aibu; Bolanle O P Musa; Saheed Gidado; Abdulsalami Nasidi
Journal:  Am J Trop Med Hyg       Date:  2016-08-15       Impact factor: 2.345

Review 5.  HIV/HBV coinfection in children and antiviral therapy.

Authors:  Sara A Healy; Sonia Gupta; Ann J Melvin
Journal:  Expert Rev Anti Infect Ther       Date:  2013-03       Impact factor: 5.091

6.  Hepatitis B Therapy in Pregnancy.

Authors:  Natalie H Bzowej
Journal:  Curr Hepat Rep       Date:  2010-09-09

7.  Comprehensive review of telbivudine in pregnant women with chronic hepatitis B.

Authors:  Teerha Piratvisuth; Guo Rong Han; Stanislas Pol; Yuhong Dong; Aldo Trylesinski
Journal:  World J Hepatol       Date:  2016-03-28

Review 8.  What physicians should know about the management of chronic hepatitis B in children: East side story.

Authors:  Hun-Jee Choe; Byung-Ho Choe
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

9.  Optimal Management of the Hepatitis B Patient Who Desires Pregnancy or Is Pregnant.

Authors:  Natalie H Bzowej
Journal:  Curr Hepat Rep       Date:  2012-05-26

Review 10.  Current antiviral therapy for chronic hepatitis B.

Authors:  Young-Suk Lim; Dong Jin Suh
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.